Dr. Saul Hertz and the Origin of Nuclear Medicine: Genealogy, Challenges, Legacy

January 17, 2018 Boston Free
Dr. Saul Hertz (Courtesy photo)
Dr. Saul Hertz (Courtesy photo)

In the 1930s and 40s, Dr. Saul Hertz revolutionized medicine with his breakthrough research establishing the use of radioactive iodine (RAI) as the cornerstone of nuclear medicine. Used today, RAI is the gold standard of targeted cancer therapy. The son of Jewish immigrants, Hertz faced many professional challenges, especially anti-Semitism, with his contributions being falsely recorded, omitted, and trivialized in medical history. More than 80 years since his research began in Boston at MGH and MIT, his story, achievements, and legacy are coming to light.

Join Barbara Hertz for an illustrated talk on Dr. Hertz’s family’s origins in Poland, the social biases that impeded his due recognition, and how his medical legacy continues to this day. A special exhibit featuring research journals, vivid photographs, and correspondence as well as family heirlooms will be on display following the lecture and available for viewing through the end of March.

+ More... - Less...
Fact Sheet
When
Wednesday, January 17, 2018, 7:00 pm - 8:30 pm
Where
New England Historic Genealogical Society
99-101 Newbury St
Boston, MA 02116
Price
Free

CJP provides the above links concerning third-party events for your convenience only. CJP has no control over the content of the linked-to websites or events they describe, and accepts no responsibility for the websites, including any advertising or products or services on or available from such sites, or for any loss or damage that may arise from your attending, or registering to attend, the described events. If you decide to access any of the third-party websites linked to below, you do so entirely at your own risk and subject to the terms and conditions of use for such websites and event attendance. CJP is not responsible or liable to you or any third party for the content or accuracy of any materials provided by any third parties. All statements and/or opinions expressed in the linked-to materials or at the described events, and all commentary, articles and other content provided at the third-party websites or at the events, are solely the opinions and the responsibility of the persons or entities operating the linked-to websites and events. The inclusion of any link on this website does not imply that CJP endorses the described event, or the linked-to website or its operator. MORE

More From...

More In...

More At...